This, together with additional advantages of qRT-PCR, such as rapid turnaround time, ease of analysis, and the use of biopsy or cytology specimens with a smaller tumor content than that needed for accurate FISH and IHC [42], suggest the feasibility of incorporating qRT-PCR into routine ALK diagnosis in NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.